211 related articles for article (PubMed ID: 16014306)
1. Chronic treatment with mianserin prevents DOCA-salt hypertension in rats--evidence for the involvement of central 5-HT2 receptors.
Silva AL; Cabral AM; Abreu GR; Pires JG; Bissoli NS; Ramage AG
Eur J Pharmacol; 2005 Aug; 518(2-3):152-7. PubMed ID: 16014306
[TBL] [Abstract][Full Text] [Related]
2. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension.
Kawanishi H; Hasegawa Y; Nakano D; Ohkita M; Takaoka M; Ohno Y; Matsumura Y
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):280-5. PubMed ID: 17324138
[TBL] [Abstract][Full Text] [Related]
4. The 5-hydroxytryptamine2B receptor and 5-HT receptor signal transduction in mesenteric arteries from deoxycorticosterone acetate-salt hypertensive rats.
Watts SW; Baez M; Webb RC
J Pharmacol Exp Ther; 1996 May; 277(2):1103-13. PubMed ID: 8627522
[TBL] [Abstract][Full Text] [Related]
5. Contribution of vascular and tubular effects of arginine-vasopressin to the development of deoxycorticosterone acetate (DOCA)-salt hypertension in rats.
Hofbauer KG; Mah SC; Wood JM; Baum HP; Hänni H; Opperman JR; Kraetz J
J Hypertens Suppl; 1984 Dec; 2(3):S333-5. PubMed ID: 6599676
[TBL] [Abstract][Full Text] [Related]
6. Concurrent administration of aqueous Azadirachta indica (neem) leaf extract with DOCA-salt prevents the development of hypertension and accompanying electrocardiogram changes in the rat.
Obiefuna I; Young R
Phytother Res; 2005 Sep; 19(9):792-5. PubMed ID: 16220573
[TBL] [Abstract][Full Text] [Related]
7. Digoxin amplifies the effects of deoxycorticosterone acetate (DOCA) in intact water-drinking rats: implications for the mechanism of DOCA hypertension?
Li M; Martin A; Liu DT; Whitworth JA
J Hypertens; 1994 May; 12(5):569-76. PubMed ID: 7930557
[TBL] [Abstract][Full Text] [Related]
8. DOCA stimulates salt appetite in Zucker rats: effect of dose, synergistic action with central angiotensin II, and obesity.
Omouessi ST; Falconetti C; Fernette B; Thornton SN
Brain Res Bull; 2007 Sep; 74(1-3):14-20. PubMed ID: 17683784
[TBL] [Abstract][Full Text] [Related]
9. Contribution of central nitric oxide to the regulation of blood pressure and sodium balance in DOCA-salt hypertension.
Seto S; Nagao S; Ozeki S; Tetsuo H; Akahoshi M; Yano K
J Cardiovasc Pharmacol; 2006 May; 47(5):680-5. PubMed ID: 16775508
[TBL] [Abstract][Full Text] [Related]
10. The 5-hydroxytryptamine2A receptor is involved in (+)-norfenfluramine-induced arterial contraction and blood pressure increase in deoxycorticosterone acetate-salt hypertension.
Ni W; Fink GD; Watts SW
J Pharmacol Exp Ther; 2007 May; 321(2):485-91. PubMed ID: 17289838
[TBL] [Abstract][Full Text] [Related]
11. Central bromocriptine-induced tachycardia is reversed to bradycardia in conscious, deoxycorticosterone acetate-salt hypertensive rats.
Lahlou S
Pharmacol Toxicol; 2001 May; 88(5):238-43. PubMed ID: 11393583
[TBL] [Abstract][Full Text] [Related]
12. Polyphenols restore endothelial function in DOCA-salt hypertension: role of endothelin-1 and NADPH oxidase.
Jiménez R; López-Sepúlveda R; Kadmiri M; Romero M; Vera R; Sánchez M; Vargas F; O'Valle F; Zarzuelo A; Dueñas M; Santos-Buelga C; Duarte J
Free Radic Biol Med; 2007 Aug; 43(3):462-73. PubMed ID: 17602962
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of intracerebroventricular injection of vasopressin in unanaesthetized normotensive and DOCA-salt hypertensive rats.
Berecek KH; Mah SC; Baum P; Hofbauer KG
J Hypertens Suppl; 1984 Dec; 2(3):S29-31. PubMed ID: 6599674
[TBL] [Abstract][Full Text] [Related]
14. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
[TBL] [Abstract][Full Text] [Related]
15. Age-dependent DOCA-salt hypertension in Brattleboro rats: the role of vasopressin.
Zicha J; Kunes J; Jelínek J
Physiol Bohemoslov; 1987; 36(1):33-42. PubMed ID: 2954169
[TBL] [Abstract][Full Text] [Related]
16. 5-HT activates vagal afferent cell bodies in vivo: role of 5-HT2 and 5-HT3 receptors.
Lacolley P; Owen JR; Sandock K; Lewis TH; Bates JN; Robertson TP; Lewis SJ
Neuroscience; 2006 Nov; 143(1):273-87. PubMed ID: 17029799
[TBL] [Abstract][Full Text] [Related]
17. Chronic activation of central alpha2-adrenoceptors prevents hypertension in DOCA-salt rats.
Cabral AM; da Silva IF; Gardioli CR; Menegaz RG
Auton Neurosci; 2000 Aug; 82(3):146-53. PubMed ID: 11023621
[TBL] [Abstract][Full Text] [Related]
18. 5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats.
Diaz J; Ni W; Thompson J; King A; Fink GD; Watts SW
J Pharmacol Exp Ther; 2008 Jun; 325(3):1031-8. PubMed ID: 18305011
[TBL] [Abstract][Full Text] [Related]
19. Enhanced hypotensive effects of the essential oil of Ocimum gratissimum leaves and its main constituent, eugenol, in DOCA-salt hypertensive conscious rats.
Interaminense LF; Leal-Cardoso JH; Magalhães PJ; Duarte GP; Lahlou S
Planta Med; 2005 Apr; 71(4):376-8. PubMed ID: 15856420
[TBL] [Abstract][Full Text] [Related]
20. Lithium prevents saline deoxycorticosterone acetate (DOCA) hypertension in the rat.
Iaina A; Shochat J; Serban I; Kapuler S; Gavendo S; Goldfarb D; Eliahou HE
J Lab Clin Med; 1982 Feb; 99(2):231-8. PubMed ID: 6278037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
